Back to
CITADEL ADVISORS LLC
ONC31 quarters
Position history for
CITADEL ADVISORS LLC's holdings in BEONE MEDICINES LTD
Yes. Citadel Advisors holds 1,425,517 shares of ONC (BeOne Medicines), worth $406.2M, as of its Q2 2026 13F filing. It increased the position by 393,219 shares (+38.1%) from Q1 2026. Citadel Advisors has held ONC since Q4 2019, across 27 quarterly 13F filings.
Current Value
$406.2M
Current Shares
1.4M
Total Value Change
+$403.8M
Total Shares Change
+1.4M
Quarter-by-Quarter History
Other major holders of ONC: BAKER BROS. ADVISORS LP